1. Home
  2. SNFCA vs DTIL Comparison

SNFCA vs DTIL Comparison

Compare SNFCA & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Security National Financial Corporation

SNFCA

Security National Financial Corporation

HOLD

Current Price

$9.25

Market Cap

242.5M

Sector

Finance

ML Signal

HOLD

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

HOLD

Current Price

$7.45

Market Cap

214.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNFCA
DTIL
Founded
1965
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
242.5M
214.7M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
SNFCA
DTIL
Price
$9.25
$7.45
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$45.00
AVG Volume (30 Days)
24.2K
261.9K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
13.51
N/A
EPS
0.60
N/A
Revenue
$344,587,538.00
$1,070,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.40
N/A
Revenue Growth
3.01
N/A
52 Week Low
$7.70
$3.53
52 Week High
$10.23
$9.62

Technical Indicators

Market Signals
Indicator
SNFCA
DTIL
Relative Strength Index (RSI) 41.15 48.22
Support Level $9.09 $6.62
Resistance Level $9.40 $7.84
Average True Range (ATR) 0.26 0.38
MACD -0.03 0.01
Stochastic Oscillator 19.48 64.62

Price Performance

Historical Comparison
SNFCA
DTIL

About SNFCA Security National Financial Corporation

Security National Financial Corp is a holding company providing insurance services. The company operates in three reportable business segments: Life insurance, Cemetery and Mortuary, and Mortgages. The life insurance segment sells and services selected lines of life insurance, annuity products, and accident and health insurance. The cemetery and mortuary segment engages in pre-need selling of funeral, cemetery, mortuary, and cremation services through its cemetery and mortuary locations. The mortgage segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and other real estate projects. It derives the majority of revenue from Life Insurance segment.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Share on Social Networks: